However, he went on to sat that it could be delayed into the Q3 2025. Bloomberg's Mark Gurman ... a whole lot more and we suspect even brighter results with the panel. When Tim Cook shared a ...

However, he went on to sat that it could be delayed into the Q3 2025. Bloomberg's Mark Gurman ... a whole lot more and we suspect even brighter results with the panel. Get ready to meet the ...

Operator Hello, and welcome to the EPR Properties Q4 2024 earnings call. [Operator instructions] Also, as a reminder, this ...

However, he went on to sat that it could be delayed into the Q3 2025. Bloomberg's Mark Gurman ... a whole lot more and we suspect even brighter results with the panel. Get ready to meet the ...

Q3 results season was mixed, with the Nifty 50 reporting 5% YoY PAT growth.(Image: iStock) The Q3 results season for FY25 delivered mixed results, with the Nifty 50 reporting a modest 5% year-on ...

Palred Technologies Q3 Results 2025:Palred Technologies declared their Q3 results on 13 Feb, 2025. The topline increased by 7.45% & the loss decreased by 28.19% YoY. Loss at ₹1.63 crore and ...

Oracle (ORCL) shares were active in extended trading on Monday after the IT giant reported fiscal second-quarter results.

NSDL reported a 29.82% growth in consolidated net profit for Q3 2024, reaching Rs 85.8 crore. The depository's total income rose by 16.2% to Rs 391.21 crore. NSDL is set for an IPO after receiving ...

The results for the third quarter of the current financial year was scheduled to be announced on Tuesday. However, the company's board meeting, through video conferencing, started at 1.30 pm and ...

Oracle (NYSE:ORCL) shares rose 0.1% in extended trading on Monday after the IT giant reported fiscal third-quarter results that missed expectations slightly, but said it topped $100B in remaining ...

Shares of Zen Technologies have plunged further by 10 per cent from previous low of ₹1,080 to close at its lower circuit following Q3 results. The stock traded nearly 34 per cent lower than Frid ...

It however pared some gains to close at Rs 2,332 per share. GSK Pharma had reported a consolidated net profit of Rs 230 crore for Q3 FY25. This marks a significant surge of nearly 400 percent from ...